O'Shaughnessy Asset Management’s State Street SPDR S&P Aerospace & Defense ETF XAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5K Sell
97
-406
-81% -$110K ﹤0.01% 2340
2026
Q1
$128K Buy
503
+80
+19% +$21.9K ﹤0.01% 2087
2025
Q4
$102K Buy
423
+47
+13% +$11.2K ﹤0.01% 2123
2025
Q3
$88.3K Hold
376
﹤0.01% 2114
2025
Q2
$79.3K Hold
376
﹤0.01% 1985
2025
Q1
$60.4K Sell
376
-250
-40% -$42K ﹤0.01% 1960
2024
Q4
$104K Buy
626
+16
+3% +$2.64K ﹤0.01% 1855
2024
Q3
$98.2K Buy
610
+310
+103% +$46.2K ﹤0.01% 1808
2024
Q2
$42K Buy
+300
New +$41.9K ﹤0.01% 1730
2024
Q1
Hold
0
1853

Other funds holding XAR

O'Shaughnessy Asset Management's XAR Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its State Street SPDR S&P Aerospace & Defense ETF (XAR) stake by 81% in Q2 2026, selling an estimated $110K and leaving 97 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

O'Shaughnessy Asset Management first reported a position in XAR in Q2 2024 and has held it in 9 quarters since. The position peaked at $128K in Q1 2026. 615 funds tracked by Wall St. Rank hold XAR as of Q2 2026.

  • O'Shaughnessy Asset Management held 97 shares of State Street SPDR S&P Aerospace & Defense ETF worth $27.5K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 406 State Street SPDR S&P Aerospace & Defense ETF shares in Q2 2026, an estimated $110K.
  • State Street SPDR S&P Aerospace & Defense ETF made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #2340 holding.
  • O'Shaughnessy Asset Management first reported a position in State Street SPDR S&P Aerospace & Defense ETF in Q2 2024 and has held it in 9 quarters since.
  • O'Shaughnessy Asset Management's State Street SPDR S&P Aerospace & Defense ETF position peaked at $128K in Q1 2026.
  • 615 funds tracked by Wall St. Rank held State Street SPDR S&P Aerospace & Defense ETF as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.